Letter: Levamisole (NSC-177023) in clinical immunotherapy.
D006801:Humans; D007167:Immunotherapy; D007978:Levamisole / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy
D007978:Levamisole